• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Achievements > LMB Nobel Prizes > 2002 – Sydney Brenner, Bob Horvitz & John Sulston

2002 Physiology or Medicine Prize – Sydney Brenner, Bob Horvitz & John Sulston

“for their discoveries concerning the ‘genetic regulation of organ development and programmed cell death’ in C. elegans”


Control of Cell Growth & Programmed Cell Death

The human body consists of hundreds of cell types, all originating from the fertilised egg. During the embryonic period, the number of cells increases dramatically. They mature and become specialised to form the various tissues and organs of the body. Large numbers of cells continue to be formed in the adult body. In parallel with the generation of new cells, cell death is a normal process, both in the foetus and adult, to maintain the appropriate number of cells in tissues. This delicate, controlled elimination of cells is called programmed cell death.

C. elegans nematode worm
C. elegans nematode worm

Sydney Brenner, Bob Horvitz and John Sulston studied how genes regulate organ development and how cells are programmed to die. By studying the life cycle of the adult nematode worm, which has just 959 cells, a short lifetime, and is transparent, it was possible to follow cell division as it happened, and ‘map’ these cells to identify the origin of the worm’s components during development. It was also possible to see what affects gene mutations had on organ development. Studying programmed cell death is important in understanding how viruses and bacteria invade cells and cancer changes them. Inducing such death is a key goal of cancer therapy.

Collaborating with Bob Waterston, John then moved onto sequencing the worm’s genome, reading the DNA code that determines the characteristics of the worm. This work led to the sequencing of the human genome, with John leading the UK team at the Wellcome Trust Sanger Institute. Using sequencing techniques developed by Fred Sanger, the human genome was completed in 2003. This is now being studied in order to improve the diagnosis of disease, develop new therapies and improve healthcare. The more we learn about the human genome the more there is to explore.


“I just loved watching the cells. It’s a beautiful thing to do and a challenge in the jigsaw-puzzling sense to get it all.”John Sulston


Dividing cells drawn by John Sulston
Dividing cells drawn by John Sulston

Primary Sidebar

Achievements

  • LMB Nobel Prizes
    • 2018 – Greg Winter
    • 2017 – Richard Henderson
    • 2013 – Michael Levitt
    • 2009 – Venki Ramakrishnan
    • 2002 – Sydney Brenner, Bob Horvitz & John Sulston
    • 1997 – John Walker
    • 1984 – César Milstein & Georges Köhler
    • 1982 – Aaron Klug
    • 1980 – Fred Sanger
    • 1962 – John Kendrew & Max Perutz
    • 1962 – Francis Crick & James Watson
    • 1958 – Fred Sanger
    • LMB Nobel Facts
  • Royal Society Awards
  • EMBO Awards
  • Academy of Medical Sciences
  • Perutz Student Prize
  • Joan A. Steitz Postdoc Prize
  • Eileen Southgate Prize
  • Technology Transfer

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed. Ok